- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Appia Bio Inc.
Headquarters: Los Angeles, CA, United States
Website: https://www.appiabio.com/
Year Founded: 2020
Status: Private
See Emerging Company Profile .
BioCentury | Jun 28, 2023
Management Tracks
Zhong, Malhotra to succeed Nicaise at Ovid
Plus: Chimerix promotes Andriole to CEO and updates from Appia, Verily and the Lung Cancer Research Foundation
BioCentury | Aug 10, 2022
Management Tracks
New CMOs at Arcus, Enanta
Plus Lamba becomes CFO at ImmPACT, and updates from Appia Bio and Quanterix
BioCentury | Feb 12, 2022
Emerging Company Profile
BioCentury’s 2021 class of emerging cell therapy companies
The 19 newcos are pushing the modality’s frontiers: tapping new cell types, reaching beyond blood cancers and rethinking manufacturing
BioCentury | Aug 5, 2021
Deals
Aug. 5 Quick Takes: Kite, Appia working on allogeneic CAR-iNKTs
Plus: Sierra Oncology-AZ, Valneva, Regeneron and more
BioCentury | May 19, 2021
Management Tracks
C-suite shake ups at Voyager, Passage; plus BioNTech, Iovance, Forbion, Aelix and more
Andre Turenne resigned as president and CEO of Voyager Therapeutics Inc. (NASDAQ:VYGR) and Omar Khwaja stepped down as the company’s CMO and head of research development to pursue other
BioCentury | May 15, 2021
Emerging Company Profile
Median seed, A round sizes have more than doubled since 2017
2021 is turning out to be a bumper year, in particular for start-ups with new modalities
BioCentury | May 11, 2021
Emerging Company Profile
Baltimore and colleagues launch NKT cell company Appia
Emerging Company Profile: Appia emerged from stealth with $52 million and a platform to scale iNKT cell production
Items per page:
1 - 7 of 7